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ABSTRACT
Adipose tissue is comprised of brown and white adipose tissues. In particular,
brown adipose tissues (BAT) or brown fat contain rich amount of beta3-
adrenoceptors (β3AR) and they are regulated by sympathetic nervous system
(SNS). Indeed, BAT contains unique protein called uncoupling protein 1
(UCP1) that causes non-shivering thermogenesis via mitochondrial
uncoupling of oxidative phosphorylation respiratory chain. Central
melanocortin system (CMS) that involves melanocortin-3 and melanocortin-4
receptors regulates energy intake and energy expenditure (EE). CMS-
mediated EE occurs through the involvement of BAT. It is known that
defective CMS signaling produces obese phenotype because of altered CMS
action in EE. Preliminary work from my research group has found the similar
kind of EE alteration and obese characteristics in melanocortin-1 receptor
deficient (MC1Re/e) mice. The aim of the present experiment centers on
finding if this defective EE in MC1Re/e mice is occurring via BAT
thermogenesis. Using mutant yellow MC1Re/e mice and wild type C57BL/6
mice, β3AR agonist CL-316243 was administered intraperitoneally to induce
BAT thermogenesis. Infrared thermography (IRT) technique was used to
measure the temperatures of interscapular area overlying BAT and lower
body (LB) area that is devoid of BAT. Results showed no significant difference
between WT and MC1Re/e mice in terms of induced BAT temperature
increment suggesting that defective MC1R responsible for reduced EE and
increased adiposity is not associated with BAT thermogenic activity. However,
small notable variance in temperature difference of BAT and LB between the
genotypes implicated the possible role of MC1R in BAT-originated heat
transmission across the body via impaired vasodilatation.
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Adipose tissues are present in multiple areas of the mammalian body in the
form of subcutaneous and visceral depots, collectively known as adipose
organ. These fat depots can be brown, called as brown adipose tissue (brown
fat/ BAT) or white, called as white adipose tissue (white fat/ WAT). Both of
these tissues are vastly innervated and vascularize but BAT contains higher
density of nerves and blood vessels (Cinti, 2005). WAT mainly helps to store
surplus amount of energy as triglycerides (TG) whereas BAT helps to burn
fats and dissipate energy in the form of heat. Brown-like adipocytes are
present in white fat depots that mimic white adipocytes in basal metabolism
and brown adipocytes during thermogenic stimulation. More importantly,
thermogenic response of brown-like adipocytes is identical to that of response
shown by brown adipocytes. These special adipocytes are termed as beige or
brite cells (Park et al., 2014). All adipocytes express a specific type of
adrenergic receptor, beta-3 adrenergic receptor (β3AR) (Mund and Frishman,
2013). Cellularly, BAT is composed of brown adipocytes which are
multilocular that encompasses sufficient amount of larger and distinctive
mitochondria. These mitochondria contain special type of protein, known as
uncoupling protein 1 (UCP1). UCP1 is accountable for non-shivering
thermogenesis, achieved via uncoupling of oxidative phosphorylation
(Ricquier, 2011). BAT ability to burn fat has made it an interesting target for
the treatment and prevention of obesity and obesity-related metabolic
diseases (Mund and Frishman, 2013).
1.1.1 Anatomical locations of adipose tissues
Depots of adipose tissue are found in various locations (Figure 1). WAT is
scattered throughout the body and are of two types- visceral WAT (vWAT),
distributed around internal organs and subcutaneous WAT (sWAT), situated
under the skin to provide insulation from heat/ cold. vWAT, based on location
is sub-classified into mesenteric, perigonadal, retroperitoneal and omental
adipose tissue. sWAT is located differently to that of vWAT i.e. found below
the skin, inside the abdominal cavity and in the intramuscular fat intermixed
[4]
within the skeletal muscles. Inguinal WAT is a prime example of sWAT that is
located on anterior region of the upper part of the hind limbs and below the
skin. In humans, sWAT is normally dispersed around the hips, thighs and
buttocks. Latest discovery of beige/brite adipocytes which are present in WAT
has modified our perception in identifying and classifying adipose tissues. To
differentiate between brown and beige adipocytes, brown adipocytes are
occasionally referred as “classical brown adipocytes”. Brown adipocytes are
predominantly distributed around the interscapular region in brown adipose
tissues (iBAT) and in axillary, paravertebral and perirenal areas. iBAT, spread
underneath the skin between the shoulders can be easily detached but
perirenal BAT is difficult to remove without taking out the whole kidney. In
humans, traces of iBAT are present in the thorax region (supraclavicular),
chest and abdomen. It was widely accepted that BAT was restricted only in
neonatal and early childhood phases and decreases as age advances. But,
positron emission tomography (PET) scan to investigate BAT has clearly
shown the presence of active and functional BAT in adult humans at distinct
anatomical sites, specifically in the upper body part like cervical,
supraclavicular, paravertebral and pericardial areas, and negligibly in
mediastinal and mesenteric areas (Virtanen et al., 2009). Brown-like
adipocytes have been discovered recently that share similar gene expression
pattern with those of brown and white adipocytes. These unique kind of
adipocytes which are distributed within WAT (mostly inguinal WAT) are known
as beige/ brite adipocytes or inducible brown adipocytes since these
adipocytes can be induced inside WAT by external stress like cold and diet
(Wu et al., 2012). Human superficial neck fat has similar genetic expression
pattern with mouse sWAT and that of deep neck fat with mouse iBAT (Cypess
et al., 2013). These discoveries have led researchers to redefine and classify
brown and beige adipocytes in more standard way.
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Figure 1: Locations of adipose tissue depots in a mouse (A) and an adult
human (B). A: In a mouse model, subcutaneous (inguinal and intramuscular),
visceral (mesenteric, omental, perigonadal and retroperitoneal) and brown
(interscapular and perirenal) adipose tissue depots are shown. B: In a human
model, subcutaneous (abdominal, femoral and gluteal), visceral (epicardial,
gonadal, mesenteric, omental and retroperitoneal) and brown (paravertebral,
supraclavicular and suprarenal) adipose tissue depots are shown. WAT-
White adipose tissue; BAT- Brown adipose tissue. (Extracted from Park et al.,
2014).
1.1.2 Characteristics and functions of adipocytes
Based on conventional classification, adipose tissues can be divided into two
types- WAT and BAT with their own distinct colors, structure, metabolic and
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biochemical functions, and gene expression patterns. WAT is the primary
organ to store energy as lipids and BAT is the organ that helps in the
regulation of body temperature by producing heat through the consumption of
stored energy. Development of WAT mainly occurs after birth when dedicated
fat storage cells are required to deliver fuel during fasting periods. UCP1 is
almost absent in WAT but UCP2, an isoform of UCP1 along with some other
genes like adiponectin, resistin, LPL and G3PDH are expressed in WAT (Park
et. al., 2014). Brown adipocytes contain high number of UCP1-riched
mitochondria. The red-brownish color of brown adipocytes is because of high
mitochondrial content. When lipolysis occurs in the course of cold exposure,
initiation of sympathetic nervous system (SNS) signaling takes place that
dispels free fatty acids via UCP1 and finally, heat is generated. Thus, BAT
primary function is to cause non-shivering/adaptive thermogenesis that
disintegrates energy as heat when exposed to thermogenic stimuli
(Nedergaard et al., 2001). BAT’s mitochondrial thermogenin protein i.e. UCP1,
upon activation by sympathetic provocations induces a proton leak across the
inner membrane leading to heat generation through respiratory uncoupling
reaction. UCP1- being the main player in BAT thermogenesis is regarded as
primary marker of brown adipocytes (Golozoubova et al., 2006). Other BAT-
localised markers are Ebf3, Eva1, Hspb7 and Pdk4 (Park et al., 2014). Since
BAT contains sufficient amount of blood vessels, thermogenic inducement is
rapid. Such generated heat is distributed all over the body via blood vessels.
BAT contains rich number of sympathetic nerves which on activation secrete
norepinephrine (NE) (Figure 2). In brown adipocytes, NE binds to G-protein
coupled cell membrane-localised β3 adrenergic receptors (β3AR). Binding of
NE to β3AR stimulates the release of adenyl cyclase that mediates the
conversion of AMP into cAMP which in turn causes the production of protein
kinase A (PKA). PKA promotes mitochondrial UCP1 expression in mainly two
ways. One way it does so is by facilitating the hydrolytic conversion of
glycerides (mono-, di- and tri-glycerides) into free fatty acids (FFAs) with the
help of intracellular lipases like MGL, pHSL and ATGL. Another pathway that
PKA follows to enhance mitochondrial UCP1 content is by the help of
biochemical processes such as gene transcription and translation and, cell
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growth and differentiation. These biochemical setups are mediated by MAPK
and ERK1/2, the kinase signaling pathways. FFAs enter mitochondria via
carnitine palmitoyltransferase 1a (CPT1a) and undergoes β-oxidation and
citric acid cycle producing NADH and FADH. These nucleotide coenzymes
are oxidized by electron transport chain (ETC) which causes proton to pump
out of mitochondrial matrix. This results in the formation of protonic force
which pulls proton back into mitochondrial matrix through UCP1. The stored
energy in protonic force is released generating heat and the overall process is
known as BAT thermogenesis.
Figure 2: Brown adipose tissue uncoupling and thermogenesis. NE-
Norepinephrine; AMP- Adenosine monophosphate; AC- Adenyl cyclase;
cAMP- cyclic adenosine monophosphate; UCP1- Uncoupling protein 1; TGs-
Triglycerides; MGL- Monoacylglycerol lipase; pHSL- active hormone-sensitive
lipase; ATGL- Adipose triglyceride lipase; MAPK- Mitogen-activated protein
kinase; ERK1/2- Extracellular signal-regulated kinase 1/2 pathway; NADH-
Nicotinamide adenine dinucleotide + hydrogen; FADH- Flavin adenine
dinucleotide + hydrogen. (Modified from Contreras et al., 2015).
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The process of transdifferentiation into brown-like adipocyte (beige/brite cells)
within the WAT is called browning or britening of WAT. Differential
expressions of several genes have also been studied to distinguish between
beige/ brite adipocytes and brown adipocytes. Tbx15, CD40, CD137 and
Slc27a1 are examples of some proteins encoded by these genes (Walden et
al., 2012; Sharp et al., 2012; Wu et al., 2012). Beige adipocytes exhibit both
white and brown adipocytes features. During basal states, they contain
unilocular, large lipid and similar gene expression pattern to those of white
adipocytes but when exposed to cold environment, beige adipocytes change
into intermediary cell structure with multilocular lipid droplets surrounding
initial lipid droplets. This causes the increased expression of UCP1 which is
one of the main characteristics of brown adipocytes. The induced browning
process of WAT is reversible. It has been reported that approximately six
weeks after the habituation to warmer condition (room temperature), the
formed beige adipocytes were retransformed into white adipocytes with
reduced level of mitochondrial UCP1 expression (Rosenwald et al., 2013). It is
controversial that whether beige cells form by the transdifferentiation of pre-
existing white adipocytes or by new adipogenesis from a subpopulation of
precursor cells (Cinti, 2009; Wang et al., 2013). Differences between BAT,
WAT and beige/brite adipocytes are summarized in the table below (Table 1).
Table 1: Distinguishing features between three types of adipocytes



























Heat generation Energy storage







Abundant Scarce Significant (on
activation)
Iron content Plenty Few Sufficient (on
activation)
UCP1 +++ Insignificant ++ (on activation)








































* indicates unclear data
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1.1.3 Differentiation of adipocytes
The development and differentiation of BAT occurs prior to birth as it protects
neonates from cold surrounding by causing non-shivering thermogenesis.
Multipotent stem cells i.e. mesenchymal stem cells (MSCs) develop into
adipoblasts and then into preadipocytes. Preadipocytes under the influence of
thermogenic agent(s) change into mature adipocytes which is the last stage of
differentiation (Rosen and MacDougald, 2006). Several sequences of mitosis
occur until preadipocytes reach G1 phase of cell cycle. The re-entering,
mitotic clonal expansion and exiting from the cell cycle continues till they gain
metabolic characteristics of mature adipocytes, morphology change and
collect cytoplasmic triglycerides. Finally, the division of mature adipocytes
stops at the end of terminal differentiation. Mixture of inducing agents
consisting of fetal bovine serum, insulin, dexamethasone and 3-isobutyl-1-
methylxanthine (IBMX) is required to bring differentiation in isolated cells of
adipose tissue depots (Tang and Lane, 2012). It is important to understand
that although both types of adipocytes have same origin (from MSCs), they
are produced from different precursor cells. Myf5 acts as a primary myogenic
regulatory factor. MSCs either differentiate into Myf5-negative cells
(adipogenic) or Myf5-positive cells (myogenic) (Timmons et al., 2007).
Adipogenic lineage produces white adipocytes whereas myogenic lineage
produces brown adipocytes. Even though white adipocytes and brown
adipocytes differ in precursor lineage, they have similar transcriptional
sequences of adipogenic differentiation. The differentiation process also
involves some common factors like key mediator of fat cell development,
peroxisome proliferator-activated receptor-γ (PPAR-γ) and CCAAT/enhancer-
binding proteins (C/EBPs) (Rosen and MacDougald, 2006; Tang and Lane,
2012).
Latest experiments have disapproved the assumptions of same precursor cell
being the source of white and brown adipocytes (Park et al., 2014). Indeed,
brown adipocytes as similar to skeletal muscles develop from Myf5-positive
precursor cell that are formed from mesenchymal stem cell (Figure 3). Mature
brown adipocytes develop from these Myf5-positive progenitor cells via
intermediary pre-adipocytes mediated by several factors like BMP7, PRDM16,
[11]
PPAR-γ, C/EBP-β and PGC-1α. Beige/ brite adipocytes are functionally
similar to brown adipocytes but are induced from white pre-adipocytes by cold
exposure or from white mature adipocytes by endogenous or exogenous
mediators like chronic cold exposure, β3AR agonists, PPAR-γ agonists’
treatment, FGF21, irisin and natriuretic peptides.
Figure 3: Differentiation of mesenchymal stem cell into white, beige/brite or
brown adipocytes. BMP7- Bone morphogenetic protein 7; PRDM16- PR
domain containing 16; PPAR-γ- Peroxisome proliferator activated receptor
gamma; C/EBP-β- CCAAT/enhancer binding proteins; PGC-1α- Peroxisome
proliferator activated receptor gamma coactivator 1 alpha; β3AR- Beta 3
adrenergic receptor; FGF21- Fibroblast growth factor. (Extracted from Park et
al., 2014).
There are several factors that result in the WAT browning process i.e. the
formation of beige/ brite adipocytes in WAT. One of the main factors is cold
exposure. In a prolonged cold environment (cold exposure for about 6 – 7
days), changes in metabolism and gene expression pattern in some cells of
WAT are seen (Rosenwald et al., 2013). Also, stimulation of precursor
differentiation into beige/ brite adipocytes occurs. Temperature of 27 – 33 oC
[12]
in vitro can directly influence the thermogenecity in sWAT but not in iBAT. It is
well-known fact that BAT thermogenesis is controlled by β-adrenoceptor
signaling pathway through sympathetic nervous system. Norepinephrine
stimulates G-protein coupled β3AR which increases intracellular cAMP level
causing fatty acid mobilization and increasing mitochondrial UCP1 expression
in beige adipocytes, finally leading to non-shivering thermogenesis. Several
old literatures have reported that catecholamines, a family of NE as well as
β3AR agonists like CL-316243 can exhibit UCP1-derived thermogenecity
(Himms-Hagen, 1990; Cousin et al., 1992; Lafontan and Berlan, 1993). WAT
browning is also achieved by thiazolidinediones, a PPAR-γ activator via
PRDM16 protein stabilization (Ohno et al., 2012). Other agents and molecules
like FGF21, cardiac natriuretic peptides, glucagon-like peptide, Tbx15 and
PRDM16 enhance both BAT mass and WAT browning; bone morphogenic
protein 7, myostatin and twist 1 increases BAT mass only; irisin, VEGF-A,
SirT1, Dbc1, brain-derived neurotropic factor (BDNF) and cyclooxygenase-2
helps in the browning of WAT and bone morphogenetic protein 8B can
intensify BAT functions (Lee et al., 2013). More studies are required to
determine how exactly these endogenous molecules would help in BAT
thermogenic process.
1.1.4 Sympathetic and sensory innervation of BAT
BAT is richly innervated by SNS and stimulation of these sympathetic nerves
is an important prerequisite for BAT-mediated thermogenesis (Morrison and
Madden, 2014). Thermogenic stimuli like chronic cold, feeding (Labbe et al.,
2015), stress (Razzoli et al., 2016), exercise, environmental enrichment and
some drugs like β3AR (Kim and Plutzky, 2016) elicit the release of
norepinephrine from its sympathetic nerve terminals and activation of BAT-
localised β3AR takes place finally leading to thermogenesis via UCP1.
Studies have found parasympathetic innervation in two minor BAT depots-
mediastinal and pericardial BAT but not in iBAT (Bartness et al., 2010). It is
also understood that BAT is supplied with sensory nerves which come into
action in response to fatty acid accumulation or aiding feedback mechanism to
normalize thermogenic-induced temperature increase to maintain thermal
homeostasis. Retrograde pseudorabies virus transneuronal tract tracing
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method has unveiled that CNS sympathetic innervation eventually ends in
BAT (Bamshad et al., 1999; Cao et al., 2004). In consistent to this discovery,
researchers have also found the greater extent of colocalization of
melanocortin-4 receptor (MC4R) in sympathetic nerves leading to BAT (Song
et al, 2008). Efforts are going on to pinpoint the precise SNS-BAT pathway
and concerned endogenous or exogenous stimuli involved in various kind of
induced thermogenesis. Pharmacological administration of MII, a MC3R/
MC4R agonist via fourth ventricular injection on decerebrated (removal of
cerebrum) rodents stimulates iBAT UCP1 mRNA expression (Brito et al.,
2007). This study implicates the potentiality of melanocortin system in
stimulating BAT thermogenesis through BAT-SNS neural set-up. Thus, better
understanding of nervous outflow of SNS to BAT and their neural
communication with central melanocortin system would benefit us to develop
novel pharmacotherapy for obesity by modulating energy homeostasis via
thermogenesis.
Sympathetic innervation of WAT and their regulation by sympathetic nervous
system (SNS) signals in the presence of various mediators provoke browning
in WAT, particularly sWAT (Park et al., 2014). Such “browning mediators” can
be irisin (secreted from skeletal muscle during physical challenge), FGF21
(secreted from liver), norepinephrine (stimulated by SNS in response to
exogenous thermogenic stimuli like cold) or natriuretic peptides (secreted from
heart). These proteins bind to their respective receptors and activate
thermogenesis directly or indirectly via P38 MAPK initiated by AR-mediated
cAMP-dependent PKA (Figure 4). PKA also releases Dio2 (that catalyzes the
T4 into T3 transformation) and lipase (that catalyzes TAG conversion into FA).
T3 and FA also contribute to thermogenic output.
[14]
Figure 4: Key regulators of the browning process and their action. WAT- White
adipose tissue; sWAT- subcutaneous WAT; FGF21- Fibroblast growth factor
21; P38 MAPK- P38 MAP kinase; AR- Adrenergic receptors; PKA- Protein
kinase A; Dio2- 5’ deiodinase 2; TAG- Triacylglycerol; FA- Fatty acid.
(Extracted from Park et al., 2014).
1.1.5 Importance of BAT in regard to environmental temperature and condition
BAT-mediated thermogenesis can be stimulated by environmental factors like
cold (cold-induced thermogenesis or CIT) and diet (diet-induced
thermogenesis or DIT) or by agents or molecules mentioned above in the
paper. CIT indicates BAT thermogenesis is totally dependent on temperature
[15]
of the surrounding i.e. cooler the periphery more stimulation of BAT activity
and vice-versa. One study regarding surrounding enrichment has provided
support for an association between outer environment and body weight (Cao
et al., 2011). The test subjects were placed in comparatively cooler
temperature, 22oC in an enriched environment accompanied by toys and
social interactions. It resulted in inducible browning of WAT and caused
significant loss of fat mass independent of diet or physical activity. Finally, this
study summarized that enriched environment in a hypothermic habitable
temperature stimulates BAT, enhances energy expenditure (EE) and also
helps in WAT browning via hypothalamic BDNF. BAT role in modulating
metabolism in colder condition highlights the capability of BAT in improving
body weight and metabolic health. We can relate socially enriched
surrounding of mice experiment with the current human society but unlike the
result of the study being mice metabolically healthy and losing weight,
humans have been confronting obesity as one of the most challenging
problem in today’s sophisticated world. Only 10% of human subjects in an
experiment conducted by Lee and his colleagues to check the prevalence of
BAT in adult human had measurable functional BAT (Lee et al, 2010).
Individuals lacking BAT tend to be obese, have weak metabolic history and
are highly susceptible to suffer from type 2 diabetes mellitus. It has been
discussed that extra WAT accumulation in obese individuals insulates body
heat and the need of BAT thermogenesis is not felt. Another factor for smaller
BAT volume and activity is due to progressing age (Cypess et al., 2009). The
relationship between environmental temperature and condition, BAT activity
and metabolic health has made us to realize the importance of each
component and how the metabolic disorder like obesity can be manipulated
partially by altering surrounding temperature. Interestingly, in the present
world of social enrichment and luxurious life, BAT can play significant role in
the development of anti-obesity medication.
1.1.6 Importance of BAT in energy metabolism
BAT plays a vital role in EE and thus helps in energy homeostasis. The main
components of EE are physical activity, basal EE and BAT thermogenesis
(Lee et al, 2013). These EE elements vary among individuals (van Marken et
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al., 2002). Null or poor physical activity leads to obesity. It has been studied
that among the obese, not only DIT is poorly stimulated but also the CIT,
therefore producing a promising relationship between BAT thermogenesis and
obesity vulnerability (Jonee and Bray, 1997; Argyropoulos and Harper, 2002;
Eikelis and Esler, 2005; Wijers et al., 2010). Animal studies involving rodents
showed BAT as a primary mediator organ for DIT and CIT. One of the
previous experiments clarified energy-producing ability of BAT by measuring
oxygen extraction across iBAT (Foster and Frydman, 1979). Also, mice fed
with both chow and high-fat diet gained lesser weight when they were made to
adapt in cold environment (Morrison, 1981). It showed an important role of
BAT in energy homeostasis via CIT. One of the mouse studies also suggested
BAT as a DIT regulator organ when high carbohydrate diet intake increased
EE by 20%, measured by blood flow to BAT (Glick et al, 1984). In one
experiment conducted at thermoneutrality, high-fat fed UCP1-KO group
gained 50% more of its initial weight as compared to wild-type mice
(Feldmann et al, 2009). At thermoneutrality, CIT is not required and this
analysis regarding diet proved the idea of BAT as a DIT mediator organ.
Therefore, DIT and CIT are important elements of total EE and directly
influence energy homeostasis and weight increase (Wiljers et al, 2009).
Rothwell and Stock in one of their paper studied the role of BAT in DIT. When
they observed rats fed with cafeteria diet (high fat and high sugar content) did
not gain weight as expected, they assumed diet-induced BAT thermogenesis
consumed extra calories (Rothwell and Stock, 1979). Knehans and Romsos
investigated the BAT activity in obese leptin deficient (ob/ob) mice. Along with
lean control, they were exposed to different temperatures (thermoneutral 33oC,
25oC and 14oC) for three weeks. SNS-stimulated BAT thermogenesis as
measured by norepinephrine (NE) turnover was higher in both ob/ob and
control group at 14oC. At 25oC, NE turnover rate in BAT was significantly
higher in ob/ob mice than control mice and at thermoneutrality, only ob/ob
mice showed positive NE turnover (Knehans and Romsos, 1982). This data
revealed the action of BAT in different temperatures and its metabolic-related
association between lean and obese phenotype. New experiment performed
the transplantation of BAT from lean wild-type mice into dorsal subcutaneous
[17]
region of equivalent age and sex leptin-deficient ob/ob mice (Liu et al., 2015).
This resulted in increased oxygen consumption and decreased total body fat
mass along with the improvement of the condition like insulin resistance. Most
importantly, the significant reduction of body weight in BAT transplanted mice
emphasizes ability of BAT in fighting obesity. Another experiment indicated
the utmost developmental differences in BAT and WAT lipogenesis of
genetically leptin receptor-deficient diabetic (db/db) mice and compared with
normally functioning mice (Trayhurn and Wusteman, 1990). The study
suggested the premature and enhanced development of insulin resistance in
the BAT of leptin receptor-deficient db/db mice. Marette et al. examined the
insulin and NE effect in isolated BAT adipocytes from obese (fa/fa) and lean
Zucker rats. The results demonstrated the reduced sensitivity of obese brown
adipocytes to NE-triggered thermogenic effects however their reaction to
dibutyryl cyclic AMP was normal. These feedbacks were aided by lower
lipolytic response and marked insulin resistance (Marette et al., 1990).
Genetic ablation of BAT by using diphtheria toxin A in UCP1 expressed cells
produced obese mice with decreased energy expenditure. The obesity was
further heightened with the supply of high fat diet causing other metabolic
disorders like insulin resistance and type 2 diabetes mellitus (Hamann et al.,
1996). Using UCP1-KO mice, Feldmann et al. demonstrated deficiency of
UCP1 causes lack of DIT and markedly enhances diet-induced obesity via
increased metabolic efficiency (Feldmann et al., 2009). This experiment also
intensified the fact that UCP1 is the sole mediator of DIT and it is important to
consider ambient temperature in BAT-related study because it influences the
result of metabolic activities. Another experiment utilizing UCP1 KO mice
showed BAT UCP1 is not required for fibroblast growth factor 21 (FGF21)
secretions (Keipert et al., 2015). Keipert and his team recently reported
neither UCP1 nor voluntary/ involuntary increment of FGF21 is essential for
maintaining energy metabolism and body weight in UCP1-KO mice (Keipert et
al., 2017).
BAT weighs 60 – 100 g in human body which is a small proportion in terms of
whole body weight and whether this small organ plays such a big role in
human total body energy expenditure has been studied time and again. As
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basal EE is an important component of total EE, studies have been conducted
to explore the contribution of BAT in influencing basal EE. Cold-induced PET
scanning study carried out in BAT-positive and BAT-negative individuals in
thermoneutral temperature (i.e. 27oC) revealed no significant differences
(Yoneshiro et al., 2011). Another human-based experiment studied in cool
environment (160C) for 2 hours before metabolic evaluation showed almost all
individuals (23/24) to be BAT positive (van Marken Lichtenbelt et al., 2009). In
short, these studies established the relationship of BAT activity with basal and
cold-induced EE. Basal EE increases correspondingly when the surrounding
temperature drops. Even the small changes in basal EE result in long-lasting
body weight changes (Cunningham, 1982; Esparza et al., 2000). Thus, BAT
ability to adjust basal EE could be utilized to compensate poorer physical
activity to help in counteracting weight gain. On cold contact, [18F]
Fludeoxyglucose (18FDG; a glucose tracer) uptake by BAT is multiplied by 10
to 12 times (Virtanen et al, 2009). If we assume glucose signifies 10% of total
BAT fuel, BAT metabolism capacity to control basal EE approximates around
50% - 70% (Lee et al, 2013). In activated BAT individuals, lesser fasting
glucose was reported suggesting metabolic role of BAT in depressing blood
glucose (Cypess et al., 2009). Using [18F] Fluoro-thiaheptadecanoic acid
(18FTHA; a free fatty acid tracer), it was reported that BAT metabolism of free
fatty acid gives total energy consumption of approximately 6 kcal/day which
was considerably less when 18FDG was used (~ 100 kcal/day) (Lee et al.,
2013). The differences in energy consumption value between two different
tracers were experienced because glucose in comparison of fatty acid is a
minor substrate of brown fat (Ma and Foster, 1986). Additionally, the utilization
of glucose (GLUT1 and GLUT4) and lipid (ATGL, HSL and MGL) by BAT
thermogenic process are shown by various rodent studies (Townsend et al.,
2014). PET scanning cannot measure intracellular lipid, a source of most of
the fatty acid fuel of brown adipocytes. However, scientists were able to mark
down BAT utilization of intracellular lipid with the help of volumetric analytical
method. One of the experiments found that one-third lipid of BAT (~ 28 g) was
used to generate ~ 250 kcal of energy during chronic cold exposure of rodents
(Lee et al., 2014). These studies have delivered solid support for thermogenic
nature of BAT and its ability to burn body fat despite its insignificant size.
[19]
BAT thermogenic property makes it one of the important components of total
EE. One experiment used two transgenic groups of mice, one with permanent
BAT deficiency and other with temporary (Lowell et al., 1993). After two weeks,
both groups gained sufficient weight to be classified as obese. One group with
temporary BAT deficiency recovered from obese condition after BAT
regeneration but the other group of permanent BAT deficiency continued
gaining weight. This breakthrough examination showed BAT effectiveness in
metabolism and body weight control. A prospective large sized cross-sectional
human experiment which included 162 fit individuals, aged 20 - 73 years
observed BAT-positive subjects had lesser body mass index (BMI), total body
fat and abdominal fat than BAT-negative subjects. It concluded by stating that
suppressed BAT activity might be the reason for body fat accumulation which
keeps adding up with advancing age (Yoneshiro et al., 2011). The correlation
of BMI and brown fat activity was also studied in further trials. In one
experiment involving 35 test subjects, BAT-positive subjects had a mean BMI
of around 4 kg/m2 lower than BAT-negative subjects (Zingaretti et al., 2009)
and another experiment containing 17 subjects showed inverse association
between high supraclavicular fat UCP1 content and BMI suggesting UCP1
responsibility in significant BMI alterations (Lee et al., 2011). These human
studies can be used as an evidence to show inverse correlation of BAT
activity and body fat and how BAT could effectively influence body weight or
vice versa. It is still not clear if BAT activity is a cause or effect of a lean body
physique. Rich accumulation of fat in body makes BAT inactive as fat itself
works as a heat insulator and requirement of BAT-mediated thermogenesis is
not realized which subsequently shrink BAT size and activity. One experiment
measuring BAT activity of 15 morbidly obese patients one year before and
after bariatric surgery demonstrated the increment of BAT-positive subjects
from 2 to 5 following the surgery (Vijgen et al., 2012). Also after the weight
loss, individuals having active BAT show higher nonshivering thermogenesis
than BAT-negative individuals. This study showed that non-obese healthy
individuals have significant volume of functional BAT and explored the
possibility of BAT recruitment in humans.
1.1.7 Drug-induced thermogenesis
[20]
Himms-Hagen et al. (1994) found that chronic treatment with β3AR agonists
(CL-316243/ CL) increases body temperature and overall energy expenditure,
primarily via increment of resting metabolic rate. Her group also discovered
enlargement of iBAT size and significant multiplication of uncoupling protein
(UCP) and cytochrome oxidase content following the treatment with CL. The
nature of drug-induced iBAT hypertrophy and UCP content was different from
that of CIT. In CL-treated rats, the drug even produced the loss of WAT weight
and size. It also induced multilocular adipocytes in WAT depots for example,
in inguinal, retroperitoneal, epididymal and mesenteric WAT. This experiment
concluded that CL causes BAT mitochondrial proliferation stimulating
thermogenesis. Thermogenesis directly affects overall energy expenditure
and promotes leanness. Another follow-up experiment by Ghorbani et al.
(1997) studied the characteristics of multilocular adipocytes that appeared in
WAT depots. They documented the substantial increment (40 – 45%) of
metabolic rate caused by CL transpires in brown adipocytes of BAT and WAT
area. It was hypothesized that the multilocular adipocytes induced in WAT
depots are the matured version of small brown preadipocytes present already
in WAT and they contain few mitochondria with or without UCP. These so-
called brown preadipocytes express β3 adrenergic receptors and become
larger in size (hypertrophy) when they react with β3AR agonists. Chronic daily
subcutaneous injection of CL (0.1 mg/kg) to 2.5 months old obese rats caused
a remarkable loss in body weight and fat pad mass without any alteration in
food intake (Umekawa et al., 1997). UCP mRNA level in BAT was increased
significantly 2 – 3 folds with the stimulation of thermogenic protein in WAT
area. Variants of UCP like UCP1, UCP2 and UCP3 display an uncoupling
action when ectopically expressed. But, studies have proved that UCP1 is the
only protein among these “uncouplers” that regulates adaptive adrenergic-
stimulated BAT thermogenesis (Nedergaard et al., 2001). CL-treated obese
group has also showed the improvement in metabolic dysfunction -
hyperglycemia and hyperinsulinemia. Lack of distinct BAT morphology and
activity in rodents’ obese condition can be treated by CL administration which
functions in vivo by reducing white fat, stimulating WAT browning and
activating BAT thermogenesis hence modifying energy homeostasis. CL was
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also found to stimulate GLUT4 (Umekawa et al., 1997) and increase in vivo
BAT glucose uptake (Olsen et al., 2014).
1.1.8 Detection and assessment of BAT activity
The techniques for detecting and assessing BAT function vary from simply
weighing BAT to advanced methods involving sophisticated instruments like
positron emission tomography combined with computer tomography (PET/CT).
The investigation of BAT function depending only on BAT weight would be
incomplete but changes in BAT weight give a basic idea that something has
affected BAT. Obese mice have less active BAT and subsequently BAT
weighs less than that found in lean mice. Acute cold condition irreversibly
decreases BAT lipids and finally its weight without affecting BAT functionality.
Fasting reduces both BAT weight and activity. Measuring BAT weight is
simple and can be used as an indicator for potential BAT modifications
demanding further analysis (Virtue and Vidal-Puig, 2013). Pair feeding method
i.e. feeding same amount of food to the hyperphagic and the hypophagic
group provide the suggestion for variations in metabolic rate. If the pair
feeding does not fix body weight differences between the groups, it means
there is a modification in metabolic rate. The important parameter to
remember while pair feeding is the exact measurement of food intake.
Although pair feeding gives the knowledge of modified energy expenditure,
added experiments should be done to confirm if the changes are due to BAT.
Remarkable weight loss to overnight deprivation of food (fasting response)
suggests hypermetabolism. Sometimes performed under pair feeding
experiment, the groups are not fed at all. The resulting significant weight loss
corresponds to hypermetabolism but this experiment cannot confirm if it is
BAT related because there might be involvement of other organs for such
hypermetabolic phenotype. There are studies done to link BAT-related
temperature changes and changes in core body temperature. There is no
decrease in core body temperature or only a minor increase of temperature
(0.25 – 1 oC) over the first hour of exposing rodents to a colder temperature
(Lomax et al., 1964). It is assumed that the initial slight increase of core body
temperature is due to elevated thermogenesis and peripheral vasoconstriction
reducing peripheral heat loss. The reaction of rodents regarding core body
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temperature following 3-4 hours of acute cold exposure depends on their
thermogenic capability. One experiment showed the incompetence of mice
kept at thermoneutrality to maintain core body temperature irrespective of
thermogenic capacity during acute cold subjection (Golozoubova et al., 2001).
The decrease in core body temperature does not always indicate the defective
thermogenic capacity, it also occurs to conserve body energy as the metabolic
rate decreases by 50%. However, this process is reversible and the animal
shows recovery from the energy preserving state (Meyer et al., 2010).
Sarcolipin gene imparts its role in shivering in muscle which also influences
core body temperature (Bal et al., 2012). Hence, these animal studies have
provided evidence for measuring core body temperature to indicate
thermogenesis but cannot assure BAT-mediated thermogenesis. When mice
are subjected to cold environment, there is rapid BAT delipidation.
Endogenous lipids invade brown adipocytes to consume or synthesize lipids
(Christoffolete et al., 2004). In one hour of cold exposure, expression of gene
lipoprotein lipase (LPL) is induced that increases lipid uptake, the first
physiological sign of BAT cold exposure (Mitchell et al., 1992). In 24 hours,
increase in glycolytic genes and enzyme acetyl-CoA carboxylase causes de
novo lipogenesis with a marked improvement in de novo lipogenic capacity
(Christoffolete et al., 2004). In one week, BAT is largely refilled with lipids and
the size of lipid droplets grows similar to that of mice kept at warmer
temperature. Stearoyl-CoA desaturase 1 (SCD1) and fatty acid synthase (FAS)
are hyperinduced in 3 weeks of cold exposure. It has been shown that not all
changes in BAT lipid content are due to altered BAT metabolic rate only.
Using lipocalin-prostaglandin D synthase KO mice (Virtue et al., 2012) and
elongation of very long chain fatty acids protein 3 (Elovl3) KO mice
(Westerberg et al., 2006), it was demonstrated that these genes cause
changes in BAT lipid content at certain temperature. In a practical setting,
BAT lipid content can be measured by histological morphometry or
biochemical means (Virtue and Vidal-Puig, 2013). Staining agent
haematoxylin and eosin stains lipid and non-lipid section of BAT giving white
appearance to lipid droplets. Following phase analysis, total white area of a
BAT section estimates % lipid content per brown adipocytes. Biochemical
methods such as Folch extraction which involves weighing of BAT, extraction
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of all lipid content by suitable solvents (chloroform: methanol) and finally
weighing the lipid after solvent removal gives the measurement of total BAT
lipid content. These various rodents’ studies have shown clear influence of
environmental temperature in BAT lipid accumulation and, also the magnitude
and duration of housing temperature should be carefully considered when
result is analyzed based on total BAT lipid content. Another important
consideration is that due to the interaction of different physiological processes
in affecting BAT lipid metabolism, the assessment of lipid content in isolated
BAT in artificial medium does not give the exact measurement of BAT
thermogenesis. Measurement of various mRNA markers accountable for BAT
activation and WAT browning gives the idea of potential BAT thermogenic
capacity rather than actual measure of BAT activity. Quantification of primary
BAT marker i.e. UCP1 and other thermogenic related markers like Elovl3,
peroxisome proliferator-activated receptor gamma coactivator 1α and 1β
(PGC1α and PGC1β) and deiodinase 2 present the information regarding
degree of thermogenic stimulation in rodents (Virtue and Vidal-Puig, 2013).
UCP1 mRNA expression rises maximum after 4h of cold treatment and falls
after 1-2 days. UCP1 mRNA level is normally expressed as a concentration
per µg of RNA and is measured in terms of total UCP1 protein per specific
BAT depot (Nedergaard and Cannon, 2013). This suggests UCP1 mRNA
level as a marker of UCP1 protein content. Elovl3 (or Cig30) is stimulated to
200 fold in BAT after a 3 days treatment in 4oC environment transferred from
30oC (Tvrdik et al., 1997). PGC1α is an important transcriptional co-activator
for the expression of BAT thermogenic and differentiation process and PGC1β
helps in cold adaptive behavior of BAT. It has been shown that PGC1α is
induced 5 fold and PGC1β is induced 3 fold in BAT when mice housed at 4oC
and 30oC are compared (Lelliott et al., 2006). Mice lacking both PGC1α and
PGC1β result in defective mitochondria and significant loss in oxidative
phosphorylation capacity (Lai et al., 2008). Deiodinase 2 enzyme transforms
thyroid hormone T4 into the active form T3. Thyroid hormone helps in BAT
initiation and development. Deiodinase 2 is induced by 10 fold upon 6 days
assimilation to cold treatment (Madsen et al., 2010). Lack of deiodinase 2
causes defective BAT thermogenesis.
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PET/CT is currently preferred method to study the morphology and function of
BAT. But, it has its own limitations. Standard uptake value (SUV) of the
radiolabeled glucose substrate gives precise data only when BAT is actively
functioning. In fact, magnitude of FDG uptake directly correlates with degree
of BAT activation. Measurement of glucose substrate uptake by FDG-PET
tends to undervalue BAT function in the influence of other biological condition
like slight cold. BAT has a preference for endogenously produced fatty acids
and TGs over exogenously provided glucose analogue. This is why there is
variation in energy consumption calculation when two different (glucose and
free fatty acid) substrates are used. Glucose uptake during PET/CT scan is
also affected by other factors like insulin. If PET scanning is done after the
meal or in insulin-defective person, BAT takes up more glucose producing
false result. This is because of the insulin effect in stimulating glucose uptake.
The extent of glucose uptake is not related with the increase in thermogenesis
or local tissue blood flow or mitochondrial UCP1 activation. It is worth
understanding that glucose not only helps in oxidation but also facilitates
anaerobic glycolysis and lipogenesis. Although using F18-FDG as a
radiolabelled substrate in PET/CT scan gives high sensitivity (i.e. able to show
the occurrence of metabolically active BAT), it is not highly specific imaging
biomarker because glucose takes part in other physiological process apart of
BAT thermogenesis. PET SUV result is affected by number of changing
factors like dosage of substrate administered, inter-subject variations, effects
of other tissues and organs in absorbing the substrate, radiotracer specific
activity, diet and substrate uptake kinetics of BAT. These entities should be
cautiously selected for the experiment as it makes differences in SUV and
activated tissue volume estimation. It is recommended to implement
quantitative dynamic PET/CT scanning merged with graphical interpretation.
PET/CT is one of the expensive methods because of its high instrumentation
cost. The subject cannot undergo repetitive exposure to PET/CT because
already on the first exposure the subject is overexposed to safety risk. So, it is
not safe to use in large population study where individuals are required to
subject for imaging more than once in short break. F-FDG PET/CT gave us
confirmation of prevalence of BAT in human but it cannot be regarded as
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perfect choice for studying BAT morphology, activation and thermogenesis
(Cypess et al., 2014).
Magnetic resonance imaging (MRI) can be used as a substitute for PET/CT.
Work of MRI in identifying BAT is based on morphological difference of BAT
from WAT. There is difference in saturated and di-unsaturated fatty acids and
water content among the two types of adipose tissues. These cellular level
variations bring changes in blood and show modifications in BAT metabolic
activity via BAT oxygenation requirement (Khanna et al., 2012). Chen and his
colleagues in their study mentioned that by using MRI they were able to
differentiate BAT from WAT based on the fact that BAT has higher water-to-fat
ratio and mitochondria-rich BAT is highly perfused making it highly susceptible
to magnetic field associated with MRI. BAT activity by MRI was intuited after
measuring hemodynamic changes accompanied by oxygenation demand
(Chen et al., 2012). Thus achieved data were found consistent when
compared to weighing dissected tissue ex vivo. Also, fMRI was capable to
track drug-induced BAT thermogenic hemodynamic changes. Another study
used MRI and CT to show the presence of big bilateral supraclavicular BAT
depots in a 3-month old human child, confirmed later by tissue histology (Hu
et al., 2012). These types of morphological, functional and metabolic
recognitions of BAT by using MRI can give scientist an improved and
alternative option to classical PET/CT BAT scanning technology.
Thermal imaging technique is comparatively newer method to diagnose BAT
activity in rodents and humans. A group of researchers showed by using
thermography technique that β3-induced dorsal surface temperature-change
relates to actual estimation of UCP1-involved BAT thermogenesis (Crane et
al., 2014). In the experiment, UCP1-null mice were used as negative control
because of lack of increment in heat production. BAT thermogenesis was
induced by β3AR agonist drug. The study validated the use of infrared
thermography in promptly evaluating BAT-mediated thermogenesis. Skin
which covers BAT in rodents is warmer than other parts of body because BAT
on stimulation produces heat that can be measured using thermal camera.
Heat, being an eventual function of BAT might not be correctly measured by
PET/CT or MRI. Thus, detection of BAT activity via measurement of
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produced-heat can be effortlessly done by using infrared thermography (IRT)
method. Highly sensitive IRT can detect temperature variation between 0.1oC.
One experiment established the fact that changes in BAT temperature as
measured by in vivo IRT increased proportionately with the increase in 18F-
FDG accumulation (Carter et al., 2011). The difference between mean skin
surface temperature overlying BAT and that of not overlying BAT increased
from 0.82oC to 1.26oC after noradrenaline injection (Jackson et al., 2001). This
study suggested IRT was able to differentiate between skin surfaces overlying
and not overlying BAT. Another study concluded that change in temperature
was significantly and consistently higher in BAT-positive individuals, assessed
by IRT and PET/CT. The temperature change after two hours of cool contact,
as detected by IRT indicates it as a promising non-invasive favorable
technique for studying supraclavicular (SCV) BAT function (Jang et al., 2014).
In another study involving healthy individuals of normal BMI with age range of
3 - 58 divided into three age groups after a standard cool challenge (20oC)
showed highly confined temperature increase in the SCV region along with a
remarkable age-associated decline in both resting and stimulated conditions
(Symonds et al., 2012). These experiments have revealed the validity of IRT
and its convenience in detecting humans’ and rodents’ BAT-mediated
thermogenesis.
1.2 Melanocortin system
The melanocortin system is composed of melanocortin peptides [α-, β-, γ-
melanocyte-stimulating hormone (MSH) and adrenocorticotropic hormone
(ACTH)] derived from proopiomelanocortin gene; five G protein-coupled
melanocortin receptors (MC1-5R); two endogenous antagonists [(agouti and
agouti-related protein (AGRP)] and two ancillary proteins (mahogany and
syndecan-3) which take part in different kind of biological functions for
example, pigmentation, energy balance, pain modulation, inflammation,
immunomodulation, temperature regulation, cardiovascular function,
neuromuscular reinforcement, sexual function, steroidogenesis and exocrine
discharge. These variant physiological functions of melanocortin system can
be used in the therapeutic treatment of diseases and ailments like skin cancer
and topical disorders, obesity, pain, inflammatory and immunologic diseases,
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cardiovascular diseases, nerve injury, erectile dysfunction and cachexia
(Gantz and Fong, 2003).
Proopiomelanocortin (POMC) preprohormone gene on post translation
produces melanocortin peptides. The cleavage of POMC by prohormone
convertases, PC1 and PC2 gives rise to number of peptides belonging to
opioid and melanocortin families. The POMC-derived melanocortin peptides
(α-, β-, γ-MSH and ACTH) contain same distinctive core structure of amino
acid: His-Phe-Arg-Trp, a property attributable for binding to a member of
melanocortin receptor family. These peptides resemble melanotropic and/or
adrenocorticotropic activity, hence called ‘melanocortin’. Along with the
production of melanocortin peptides, POMC cleavage also generates opioid
peptide called β-endorphin and corticotrophin-like intermediate lobe peptide.
In the rodent, POMC is primarily situated in the intermediate lobe of pituitary
gland, in the arcuate nucleus (ARC) of hypothalamus and in the nucleus of
solitary tract (NTS) of brainstem (Joseph et al., 1983). However, POMC is
also found in other areas like skin, pancreas, gut and placenta (Smith and
Funder et al., 1988). It is well-known that melanocortin system is distinctively
controlled by two internally produced antagonists which are agouti and agouti-
related protein (AGRP) (Ollmann et al., 1997). Expression of agouti in hair
follicular epithelial cells and its secretion controls adjacent follicular
melanocytes’ melanin appearances. AGRP is manifested in neuropeptide Y
neurons (NPY) of ARC and in the adrenal cortex (Minor et al., 2009).
1.2.1 Melanocortin receptors
All five recognized melanocortin receptors, MC1R, MC2R, MC3R, MC4R and
MC5R are named according to the order of cloning and are members of G
protein-coupled receptor family. Expressed in number of locations, these
receptors have significant affinities for particular melanocortin ligands.
Stimulation of melanocortin receptors by ligands and antagonists cause
specific downstream signaling cascades and manifest various physiological
and homeostatic functions mediated through melanocortin system.
MC1R is primarily expressed in melanocytes of hair and skin and participates
in the stimulation of eumelanin (black/brown) and pheomelanin (red/yellow)
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pigmentation in many organisms (Rees, 2003). Binding of α-MSH to MC1R
increases intracellular cAMP production and subsequently increases
eumelanin: pheomelanin ratio giving rise to darker type of pigmentation (Cone
et al., 1996). If agouti (an endogenous antagonist) binds to MC1R, it hinders
the α-MSH activity at this receptor thus enhancing pheomelanin pigmentation
and making red/ yellow a dominant pigmentation. Resulting manifestation of
unusual MC1R action can be studied through agouti yellow mice (Ay) which
have overly expressed agouti peptide, the reason why they are yellow
ectopically (Wolff et al., 1999). These yellow mice are also physiologically
obese because highly expressed agouti antagonist also act on MC4R that
signals via various biological process causing obesity. MC1R also arbitrates
anti-inflammatory and immunomodulatory properties due to its expression in
leukocyte cells. MC1R is also present in vascular endothelial cells showing
vasodilative effect (Rinne et al., 2015). Expression of MC1R is seen in
macrophages which mediates anti-inflammation via α-MSH (Li and Taylor,
2008).
MC2R controls the action of ACTH receptor which is located on the adrenal
cortex and helps in the regulation of corticosteroid and adrenal gland
secretion in hypothalamic-pituitary-adrenal axis. MC2R is also found in
adipose tissue of rodents and humans. It shows lypolytic action in mice
(Wikberg, 1999).
MC3R is primarily expressed in hypothalamus and in lower level in limbic
areas of central nervous system (CNS). It plays crucial role in physiological
processes like energy balance, cardiovascular regulation and natriuresis
(Roselli-Rehfuss et al., 1993). Preferential ligands for MC3R, α- and γ-MSH
control natriuretic effects. MC3R is responsible for the regulation of energy
homeostasis. This was proved by one of the experiment when scientists
observed morbid obesity in MC3R deficient mice (Chen et al., 2000). The
MC3R-/- mice, after 4 – 6 months of care unveiled increased adiposity,
decreased lean mass and greater feed efficiency than control mice. The
feeding behavior and metabolic rates were consistent for all mice during
whole process. MC3R is expressed in POMC neurons in hypothalamus ARC.
On peripheral parenteral administration of a potent and selective MC3R
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agonist (D-Trp8-γ-MSH), food intake in mice was stimulated which implicates
inhibitory autoreceptor action in POMC neurons (Marks et al, 2006). These
studies suggest the multifaceted and complex role of MC3R in the process of
energy homeostasis as inhibitory anorexigenic effect of MC3R in POMC
neurons is overruled by combined anorexigenic consequence when MC3R
deficient mice lacking MC3R gene showed phenotypic obesity. Apart from
MC3R expression in the CNS, it has also been found in minor quantity in other
surrounding organs such as in adipose tissue, skeletal muscle, heart, kidney,
stomach, duodenum, pancreas and placenta (Gantz et al., 1993; Ellacott et al.,
2006). MC3R is also found responsible in salt-sensitive hypertension (Ni et al.,
2003).
MC4R expression in CNS and its greater prevalence in the other organs and
tissues than that of MC3R signify the diverse and valuable physiological
functions of MC4R in maintaining energy homeostasis along with autonomic
and neuroendocrine functions. MC4R is expressed in the multiple sites of
rodent brain i.e. in amygdala, brainstem, cerebellum, cortex, hippocampus,
hypothalamus, midbrain, thalamus and striatum (Mountjoy et al., 1994; Kishi
et al., 2003). The primary ligand for MC4R is α-MSH and experimental
evidence has revealed that MC4R is present wherever α-MSH shows its
binding tendency (Tatro et al., 1990). In a study conducted by Huszar and co,
deactivation of MC4R gene in MC4R deficient mutant mouse (MC4R-/-)
resulted in age-related obesity disorder accompanied by increased linear
growth and symptoms like hyperphagia, hyperglycemia and hyperinsulinemia
(Huszar et al., 1997). These phenotypic manifestations were found similar to
that of agouti yellow mice deprived of MC1R, a gene responsible of hair and
skin pigmentation suggesting agouti obesity syndrome is due to central
melanocortin signaling antagonism mediated through MC4R interference. Also
due to widespread expression of MC4R in organs and tissues other than CNS,
it is involved in other physiological roles like cardiovascular regulation, pain
processing, sexual behavior and penile erections which are controlled by CNS
(Tao, 2010).
MC5R expression is found mainly in exocrine tissues such as sebaceous,
adrenal and lacrimal glands. It helps in production of exocrine gland
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secretions. Targeted deletion of MC5R gene in mice causes intense disruption
of water repulsion and thermoregulation because of lower production of
sebaceous lipids. MC5R is also essential for the production of harderian gland
porphyrins and ligand-controlled lacrimal gland secretion of protein (Chen et
al., 1997). Defective pheromone secretion in MC5R null mice causes
aggression and protective behavior modifications (Morgan et al., 2004). Due
to exocrine role of MC5R in synthesizing and secreting glandular secretion, it
can be used as potential gene-level target for therapeutic treatment of topical
disorders like dermatitis, acne and skin rashness (Gantz and Fong, 2003).
1.2.2 Role of central melanocortin system in regulating energy homeostasis
The central melanocortin system comprises neurons expressing POMC and
its cleaved derivatives, neurons containing AGRP and CNS neurons which
express MC3R and MC4R. These components undergo various processes
and help in the regulation of energy homeostasis. Peripherally expressed
MC3R and MC4R also possess probable energy homeostatic property. The
two strains of agouti mouse, lethal yellow (Ay) and viable yellow (Avy) are
produced by spontaneous mutation. Phenotypically, Avy mouse has black
spots making it to appear as typical black/ yellow agouti color as compared to
bright yellow coat color of Ay mouse (Yen et al., 1994). Dominant yellow color
mutations at the mouse agouti point leads to recognizable effects including
obesity, hyperinsulinemia, somatic growth activation, tumorigenesis and
external coat coloration (Perry et al., 1994). As mentioned earlier, obesity in
agouti mouse occurs due to antagonistic effect of agouti peptide at MC1R and
MC4R. In fact after the cloning and hypothalamic localization of MC4R, it was
supposed that agouti peptide cause an antagonistic effect in MC4R (Lu et al.,
1994). Later, it was confirmed after the experiment on MC4R null mouse
(Huszar et al., 1997). Use of MC3R/ MC4R agonist, Melanotan II (MTII) in
wild-type littermates, agouti and leptin deficient ob/ob mice resulted in
reduced food intake whereas MC3R/ MC4R antagonist- SHU9119 increased
night time and fast-induced food intake. This implicates inhibitory effect of
melanocortin system stimulated by altered food intake acts via centrally
expressed MC3R and MC4R (Fan et al., 1997).
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Adipocytes-produced leptin mixes into circulation, binds to centrally expressed
leptin receptors and exerts its effect on energy homeostasis. Central
melanocortin system imparts necessary role in intermediating the effects of
leptin. Leptin receptors are highly localized in ARC’s POMC neurons.
SHU9119, a central melanocortin antagonist moderately reverses the
anorexigenic effect of externally administered leptin molecule. This finding
shows the central melanocortin system is the downstream result of leptin
signaling cascade and is important in exerting leptin’s effect (Seeley et al.,
1997). Leptin regulates POMC and AGRP mRNA levels and the consistency
of these proteins during exceptional energy homeostatic state like fasting and
lactation (Chen et al, 1999; Mizuno et al., 1999). In ex vivo sample maintained
at electrophysiological state, leptin controls the firing rate of POMC and
AGRP/ NPY neurons in ARC (Cowley et al., 2001; Takahashi et al., 2005).
Proteins taking part in leptin receptor signaling cascade like SOCS-3 and
pSTAT-3 in ARC POMC neurons are also controlled by leptin hormone
(Munzberg et al., 2003). Although leptin effects are mediated by POMC
neurons, Boston and his coworkers demonstrated that the effects of central
melanocortin facilitated disruptive POMC signaling and lack of leptin on weight
increase in double-mutant yellow leptin deficient (Ay/a lepob/lepob) mice were
independent and synergistic. Also, they found that leptin resistance is due to
inactive leptin signaling (Boston et al., 1997). Exogenously administered leptin
can lead to energy homeostasis aided by MC4R by modifying nutrient intake
(Trevaskis and Butler, 2005). Action of leptin does not depend only on MC4R-
transduced central melanocortin pathway. It is important to note that leptin
resistance is a resultant of various factors which arise from obesity. Anorectic
neuromodulators like NPY and-, corticotrophin releasing factor (CRF) act
autonomously or subsequently to MC4R signaling disregard of leptin
resistance (Marsh et al., 1999).
Central melanocortin system is not only actively involved in the regulation of
energy homeostasis via factors like leptin but also shows its action in
conciliating hunger and satiety cues. POMC and MC4R mRNA are also
situated in the dorsal vagal complex (DVC) of the brainstem (Mountjoy et al.,
1994). DVC as we know is an end-point for vagal afferent nerve fibers and
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vital in instant transmission of satiety related information between stomach
and brain. MTII, a MC3R/ MC4R agonist decreases a meal size whereas
antagonist SHU9119 increases a meal size, both regardless of meal
frequency (Sutton et al., 2005). This data acts as an evidence for satiety
inducing characteristics of central melanocortin system. Cholecystokinin
(CCK), a popular satiety factor and meal-stimulated satiety activates NTS
POMC neurons (Fan et al., 2004). Upsurge of NTS pERK (phosphorylation of
extracellular-signal regulated kinase) by CCK or MTII can be retreated with
the prior administration of antagonist SHU9119 which advocate that tonic
pERK increment is reliant on pristine MC3R and MC4 signaling, supporting
the proof for CCK interaction with central melanocortin system (Sutton et al.,
2005). Imparting important role in CCK-induced satiety cues, central
melanocortin system is also responsible for mediating hunger cues or meal
initiation. Ghrelin, an endogenous hunger-inducing hormone triggers nutrient
demand needed for the body. Before the meal, the systemic level of ghrelin is
increased which lowers after food intake. This indicates importance of ghrelin
in meal commencement. Also, lowering of after-meal ghrelin level is directly
correlated with ingested nutrient caloric value (Callahan et al., 2004).
Expression and release of ghrelin in hypothalamic region of CNS stimulates
the synthesis of orexigenic peptides and an inhibition of POMC firing (Cowley
et al., 2003). This region of CNS also contains NPY/AGRP neurons. ARC
NPY neurons activation via growth hormone secretagogue receptor (GHSR)
increases the appetite (Willesen et al., 1999). Prolonged central administration
of ghrelin peptide in rat initiates meal intake and subsequent increment of
body weight without affecting plasma insulin, glucose, leptin and GH level.
There is also rise of both NPY and AGRP mRNA levels in ARC (Kamegai et
al., 2001). These studies suggest the interactive connection between hunger
stimulant ghrelin, satiety stimulant leptin and central melanocortin system
mainly involving MC3R and MC4R and their important role in mediating
energy homeostasis via appetite and surfeit cues.
Genetic deletion of melanocortin 4 receptor function in mice produces MC4R
null mice with melanocortin obesity syndrome that have phenotypic
resemblance with agouti yellow mice. The cause of obesity in these strains of
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mice is due to hyperphagia and hypometabolism. However, it has been
showed that hyperinsulinemia occurs prior to these symptoms (Fan et al.,
2000). Melanocortin system can also modulate pancreatic sympathetic
signaling cascade. MC4R null mice do not have natural homeostatic
approaches to diet fat modifications (Butler et al., 2001). They become
oversensitive to obesity-causing effects of high fat diet. These results are not
seen in leptin deficient and MC3R null mice. It is also discovered that MC4R
null mice are not able to increase energy expenditure despite being
hyperphagic. However, this incapability is not associated with environmental
temperature as MC4R null mice adapt to lower temperature by BAT mediated
thermogenesis. But, again this cold environment adaptation is not seen in
ob/ob mice and leptin administered MC4R null mice (Marie et al., 2000; Butler
et al., 2001).
Role of central melanocortin receptors in metabolism and obesity can be
further studied in terms of whether it has any association or contribution in
cardiovascular disorders. Metabolic syndrome, defined as a cluster of
biochemical as well as physiological defects with the symptoms like
abdominal obesity, hyperlipidemia, hyperglycemia, hypertension and low HDL
(high-density lipoprotein) cholesterol level elevates the risk for coronary heart
disease and other health problems like diabetes. Regarding the connection
between metabolism and cardiovascular diseases, there is several hypothesis
and studies on the effect of central melanocortin system in the physiological
and pathological role of cardiovascular system. In one study, it was
demonstrated that mean arterial pressure (MAP) was elevated by chronic
stimulation of hypothalamic MC3R/ MC4R with no change in food intake.
However, MAP remained unchanged following hypothalamic MC3R/ MC4R
inhibition but in this case, there was significant weight increment. This
experiment was in consistent with the hypothesis that intact MC3R/ MC4R are
essential in elevating arterial blood pressure in obese individuals (Kuo et al.,
2003). Another experiment involving homozygous and heterozygous MC4R
deficient mice confirmed this hypothesis by showing homozygous MC4R null
mice were neither hypertensive nor salt sensitive even after possessing many
features of metabolic syndrome like obesity, hyperglycemia, hyperinsulinemia
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and hyperleptinemia (Tallam et al., 2005). Hence, these data supports the
competence of central melanocortin system in obesity and obesity-associated
cardiovascular disorders like hypertension and tachycardia.
1.2.3 Role of central melanocortin system in adiposity
MC4R signaling helps in the regulation of metabolism. To investigate this,
pair-feeding studies had been done that have shown MC4R null mice had
increased fat pad accumulation in the absence of hyperphagia (Marie et al.,
2000). This experiment also exposed significant weight differences between
female test and female control groups which were not seen in male group that
suggest the possible role of sex steroid hormones in metabolism. More
buildup of fat pad in male test mice than its control without significant weight
differences indicates the importance of central melanocortin pathway in
maintaining adiposity. This study has also stressed defective MC4R signaling
enhances caloric efficiency, the result which can be seen in agouti mice and
also in MC3R null mice. Another study done few years later tried to focus on
hyperphagia rather than hypometabolism for the cause of early-onset obesity
(Weide et al., 2003). MC4R also affects lipid storage in liver and increase in
lipogenic liver enzyme might be associated with adiposity (Albarado et al.,
2004). MC3R that is expressed on adipocytes can modulate fat mass content
as displayed by MC3R null mice, which have greater adiposity and feed
efficiency value but reduced lean mass as compared to wild types (Chen et al.,
2000). POMC-/- mice are found to be hypometabolic, hyperphagic to high-fat
diet and obese but show regular reaction to anorexigenic peptide YY or PYY3-
36 (Challis et al., 2004).
Central melanocortin system plays certain part in BAT-mediated
thermogenesis by modulating sympathetic nerve activity that innervates brown
fat. Agonist of MC3R/ MC4R (e.g., α-MSH) stimulates sympathetic nerve
activity and elevates BAT temperature whereas antagonist (e.g., AGRP)
lowers BAT temperature by inhibiting activity of BAT-innervated sympathetic
nerve (Yasuda et al., 2004). Ventricular administration of MTII (MC3R/ MC4R
agonist) in hindbrain and forebrain region increases UCP1 mRNA expression
in BAT, mediated by sympathetic outflow to BAT (Williams et al., 2003). These
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experiments indicate that central melanocortin system can regulate
sympathetic nerve activity of BAT resulting in thermogenesis and
subsequently helps in energy expenditure. Leptin, an adipocyte-derived
satiety-inducing hormonal factor contributes to EE by BAT mediated
thermogenesis via hypothalamus (Pandit et al., 2017). Among other signaling
cascades, regulation of BAT thermogenesis is done by preoptic area - rostral
raphe pallidus (POA-rRPa) pathway and dorsomedial hypothalamus/ dorsal
hypothalamic area (DMH/ DHA) pathway. It has been suggested that neurons
expressing leptin in DMH raise sympathetic outflow to BAT and the other way
round. Central administration of leptin in ob/ob mice brought about normal
body temperature which directs that leptin regulates EE by initiating BAT
activation and thermogenesis via DMH/ DHA neurons (Jo and Buettner, 2014).
By injecting pseudorabies virus (which acts as a polysynaptic retrograde
tracing agent) into iBAT, sympathetic outputs from brain to interscapular
region have been discovered (Zhang and Bi, 2015). It was reported that iBAT-
injected pseudorabies virus were significantly found in various hypothalamic
areas like paraventricular hypothalamus (PVN), lateral hypothalamus (LH),
DMH, ARC and POA whereas in ventromedial hypothalamus (VMH), few or
no virus was found. Upon viral injection into WAT, viruses were found in PVN,
DMH and POA area. Discovery of these active sites have acknowledged that
the downstream signaling from various hypothalamic regions regulate
sympathetic nerve activity of BAT and WAT which initiates BAT
thermogenesis along with WAT browning. However, Butler et al. found no
involvement of BAT or leptin in DIT but suggested the connection of MC4R in
mediating thermogenesis caused by dietary changes (Butler et al., 2001).
These revolutionary findings have propounded that BAT thermogenesis is
centrally supervised by hypothalamic melanocortin signals which leads to
energy homeostasis and the possibility of targeting central melanocortin
receptors during the metabolic disorders to tempt enduring energy balance
state.
Cold-induced BAT thermogenesis is regulated by POA-DMH-rRPa pathway
(Zhang and Bi, 2015). POA of hypothalamus contains sensory neurons that
sense the external hypothermic (cold) condition (Figure 5). rRPa contains
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sympathetic premotor neurons that react to thermoregulatory information
received from POA and DMH by generating heat if necessary. This DMH-
rRPa pathway also centrally governs stress-induced BAT thermogenesis and
hyperthermia. Stress mediates through DMH to activate rRPa neurons and
hence cause thermogenesis resulting from sympathetic outflow. Upstream
neural network from DMH caused by stress is not properly understood.
Expression of anorexigenic (appetite-suppressing) POMC neurons and
orexigenic (appetite-enhancing) NPY/AGRP neurons in the ARC also helps in
central maintenance of thermoregulation. Similarly, presence of NPY neurons
in the DMH and, orexin and MCH neurons in the LH also helps in temperature
equilibrium. Excessive high fat (HF) diet modifies the function of these
neurons to eventually cause energy homeostatic state by increasing energy
expenditure via BAT thermogenesis. However, central neuronal pathway in
this regard (i.e. diet-induced thermogenesis) is not properly defined.
Endogenous factors like BMP8 (BAT), estrogens (ovarian) and GLP-1
(intestine) mediates through VMH. These organ-specific stimulations are
considered peripheral signals which also cause BAT activation or beiging and
involvement of VMH demonstrates the secondary contribution of
hypothalamus in BAT thermogenesis via neuroendocrine circuit. Above figure
shows that central as well as peripheral pathway acts on classical BAT (iBAT)
and beige/ brite cells in white adipose tissue (WAT). These both cells are
sympathetically controlled by hypothalamic neural populations.
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Figure 5: Model of hypothalamic neural regulation of BAT thermogenesis.
(Solid lines/arrows indicate established pathways and dash lines/arrows
indicate unascertained pathways]. BAT- Brown adipose tissue; iBAT-
interscapular BAT; POA- Preoptic area; DMH- Dorsomedial hypothalamus;
rRPa- rostral Raphe pallidus; POMC- Proopiomelanocortin; NPY-
Neuropeptide Y; AGRP- Agouti-related peptide; ARC- Arcuate nucleus; MCH-
Melanin concentrating hormone; LH- Lateral hypothalamus; BMP8- Bone
morphogenetic protein 8; GLP-1- Glucagon-like peptide 1; VMH- Ventromedial
hypothalamus; PVN- Paraventricular hypothalamus; SNS- Sympathetic
nervous system. (Extracted from Zhang and Bi, 2015).
1.2.4 Other functions of central melanocortin system
It is well-known that MC4R mediates the linear growth. Genetic or natural
disruption of MC4R function causes enhanced linear extension in rodents and
humans (Huszar et al., 1997; Farooqi et al., 2003). Even though the systemic
GH level is reduced in obese children, effects such as hyperinsulinemia,
hyperprolactinemia, increased insulin-like growth factor 1 (IGF-1) and
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increased insulin-like growth factor binding protein 3 (IGFBP-3) levels are
experienced (Attia et al., 1998; Park et al., 1999). MC4R suppression in
rodents result in obesity similar to human but along with weight gain in rodents,
increase in linear growth and muscle mass are also seen. In fact, there is
overall increase in lean mass in MC4R null mice. In agouti-derived yellow
obese mice, increased level of serum IGF-1 during the early stage (2nd – 4th
week) of life-cycle is assumed for enhanced longitudinal growth despite
reduced systemic GH level (Wolff et al., 1999). One experiment summarized
MC4R blockade by chronic infusion of central melanocortin antagonist,
SHU9119 produced an obesity phenotype without any notable side-effects on
the reproductive and somatotropic axes [GH, IGF-1, growth hormone
releasing hormone (GHRH)]. In this investigation, hypothalamic neuropeptide
Y (NPY) gene expression was specifically inhibited to suppress NPY-induced
hyperphagia. Another experiment found that central melanocortin pathway
can alter the GH secretion pattern but not the overall GH secretion level
(Watanobe et al., 2003). Established anatomical data supports the idea of
central melanocortin system in mediating GH secretion by displaying the close
association between hypothalamic somatostatin and POMC neurons (Fodor et
al., 1998). Arcuate nucleus contains elements of melanocortin and
somatotropic system like POMC, AGRP, GHRH and somatostatin receptors
like ss1 and ss2. Indeed, some POMC neurons express active binding sites
for somatostatin. α-MSH interacts with somatostatin in PVN. Limited data
implicate the necessity of more researches to specifically understand the
effect of central melanocortin system in linear extension.
In addition to affecting linear growth, central melanocortin system also affects
bone metabolism subsequently contributing to increased lean mass as seen in
MC4 null mice. It has been found that there is higher expression of Rankl and
Cart factor in the bones and hypothalamus of MC4R null mice (Elefteriou et al.,
2005). Normal bone formation and reduced bone resorption occurs in half-
year old MC4R null mice. MC4R deficient individuals have decreased serum
Dpd and crosslaps CTX. One research group has reported that all five
melanocortin receptors, MC1-5R are expressed in different concentration in
osteoblast-like and osteoclasts cells (Zhong et al., 2005). Additionally, the
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authors advised direct and indirect effects of POMC-derived hormones on
bone cell subspecies and the involvement of steroidal hormone secretion. α-
MSH, a melanocortin peptide directly stimulates bone cell proliferation but in
vivo it causes reducing effect in trabecular bone which is mediated by α-MSH
action that decreases adiposity and pancreatic anabolic hormones (Cornish et
al., 2003). ACTH helps in the generation of chondrocyte phenotype from
mesenchymal progenitor cell populations and also enhances production of
matrix and differentiation of responsible chondrocytes (Evans et al., 2004).
One study induced cachexia in MC3R null mice and wild-type mice by
tumorigenesis (Marks et al., 2003). Cachexia is defined as a chronic metabolic
disease because of decreased appetite (or food intake) and increased
metabolism of lean as well as fat mass. In the experiment, researchers
observed the remarkable loss of lean mass in MC3R null mice than wild-type
controls. This experiment tried to explain the crucial role of MC3R in
maintaining lean mass in a physiological abnormal state. Also, due to absence
of functional MC3R in the diseased MC3R null mice, energy homeostasis was
severely disrupted along with unregulated lean mass. The anatomical,
pharmacological, physiological and pathological evidences to show the
expression of central melanocortin system components during the somatic
growth, osteoregulation and pathological studies illustrate the importance of
overall melanocortin signaling in the regulation of lean mass in rodents and
humans.
2 AIM OF THE EXPERIMENT
The present experiment has used genetic mutant MC1Re/e yellow mice having
C57BL/6 background. MC1Re/e mice are produced by frameshift mutation
between exon 4 and 5 that results in non-functional MC1R (Robbins et al.,
1993). They have yellow fur color due to MC1R mutation that causes higher
pheomelanin expression in the melanocytes of hair. In one of the unpublished
experiment performed by our research group, it was found that MC1Re/e mice
fed on standard chow diet had remarkable higher adipose tissue mass and
decreased whole body energy expenditure than their WT counterparts.
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Interestingly, these phenotypic changes seen in MC1Re/e mice coincide with
the characteristics of MC3R and MC4R deficiency. On the other hand, it is
already known that central melanocortin system (MC3R and MC4R) regulate
body temperature via BAT thermogenesis. We wanted to know if the
increased adiposity and decreased energy expenditure as seen in MC1Re/e
mice is related with BAT thermogenesis thereby checking the importance of
MC1R in mediating BAT thermogenesis.
3 MATERIALS AND METHODS
3.1 Animals, care and ethics
The experiment was carried out on 3 to 4 months old adult male mice. The
mice were housed in the Central Animal Laboratory, University of Turku.
Temperature was maintained at 21 ± 2 oC with relative humidity of 36 ± 2%.
Twelve hours light/dark cycle was maintained throughout the experiment
without any restriction on water and diet. Diet provided was standard chow
diet. The 3R principle of replacement, reduction and refinement was followed.
Euthanasia was done after the completion of experiment meeting standard
guidelines. The experiment was performed in accordance to national and E.U.
directives regarding animal care during experiment and approved by national
animal care and use committee.
3.2 Animal models and drug used
Two different varieties of male adult mice were used- wild-type C57BL/6
(black) mice and mutant MC1Re/e (yellow) mice on a C57BL/6 background.
MC1Re/e yellow mice are homozygous for the MC1Re allele and they have
defective MC1R function because of single base deletion mutation. All the
mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA) and
maintained in Central Animal Laboratory, University of Turku.
CL-316243 (1.00 mg/kg, CL-316243 disodium salt, Tocris Bioscience, UK), a
highly selective β3AR agonist was administered i.p. to induce BAT
thermogenesis. Food and water were provided ad-lib in an indoor environment
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of set room temperature (21 ± 2 oC). Saline (0.9%, Natriumklorid Braun 9
mg/ml, B. Braun Melsungen AG, Germany) was used as control. The handling
was avoided as much as possible because stress caused by handling also
influences body temperature and drug effect can be accentuated.
3.3 Experimental setup
Prior to main experiment, pilot study was conducted for few weeks taking only
wild-type (WT) mice and injecting them with saline and CL (i.p). The primary
reason behind this pilot project was to determine the experimental setup. We
drew some important conclusions that would be applied in the main
experiment. Sedative agent (medetomidine) needs to be used to calm the
mice because in awake mice, the stress of handling and injection increases
the BAT temperature and hence the CL-effect could not be differentiated.
Medetomidine-induced hypothermia was managed by using heating mat and
recovery of induced sedation was made possible by atipamezole i.p. injected
at the end of experiment. We also noticed that shaving of ROI (interscapular
and lower body region) was necessary as infrared camera can precisely
detect and measure the temperature in the shaved area. The procedure was
mainly based on the published paper where infrared camera was used to
specifically measure BAT thermogenesis in vivo (Crane et al., 2014).
Comparison of skin temperature between interscapular region (overlying BAT)
and lower body region was necessary to compare the CL-induced BAT
temperature increment with normal body-temperature rise (Jackson et al.,
2001).
3.3.1 Main experiment
Total of 18 male mice (9 WT and 9 mutant (MC1Re/e)) were divided into six
groups with each group containing same genotype mice. The interscapular
and lower body regions were shaved one day prior to imaging basal body
temperature. Shaving was carried out under the influence of isoflurane
anesthesia (4% induction, 1.5% maintenance; Attane vet, 1000 mg/g, Piramal
Healthcare, UK) followed by trimming (Ordinary trimmer, Isis, Aesculap,
Germany) and shaving (Veet hair removal cream, Reckitt Benckiser, UK).
Then, dorsal body temperatures were imaged with the help of infrared camera
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(FLIR T620bx, FLIR Systems AB, USA) in awake, freely moving mice after
two hour habituation to individual housing in a new cage. On the following day,
same groups of mice were injected i.p. with either saline or CL in a
randomized crossover manner. Before saline/CL injection, mice were
anesthetized with medetomidine (0.33 mg/kg, Cepetor vet 1mg/ml, ScanVet
Oy, Finland) and then transferred to heating mat (776 X 274 mm, 230 V, 41.5
W, MAT Solutions BV, Netherlands) to counter the hypothermic effect of
medetomidine. Infrared images were then shot (referred as ‘images 00:00’ or
‘baseline images’) by keeping mouse out of heating mat on open-top cage.
After the saline/CL administration, infrared images were taken in various time
points in 00:20, 00:40, 01:00 and lastly in 02:00 hours before the
administration of atipamezole (2.00 mg/kg, Antisedan vet 5mg/ml, Orion
Pharma, Finland) i.p. (Figure 6).
Figure 6: Time-based flowchart showing the procedure for the measurement
of BAT thermogenesis using infrared thermography technology. HM – Heating
Mat.
Below are the examples of infrared images for treated genotype which were
produced using FLIR software (Figure 7). Rectangular and circular/oval box
were drawn in the image to restrict the measurement within the interscapular
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ROI (represented by Bx1) and lower body ROI (represented by El1)
respectively. Interscapular ROI encompasses BAT and lower body ROI
encompasses region of body devoid of BAT and works as reference to body
temperature. The image precisely shows the magnitude of maximum,
minimum and average temperature within ROIs. Colorful linear side bar is the
index for extent of total body temperature that varies between the images due
to the software automatic operation to make suitable contrasts however higher
limit does not exceed 40oC.
Figure 7: Representative infrared images of WT and MC1Re/e mice 20 minutes
after saline/CL administration. WT- Wild type; MC1Re/e- MC1R deficient; BAT-
Brown adipose tissue; LB- Lower body.
3.4 Preparation of drug solution
Powder grade CL was mixed with saline to prepare 20 aliquots of stock
solution (1 mg/ml) and stored in deep freezer (-70oC). Dose of CL
administered was 0.001 mg/g and suitable concentration was prepared
depending on weight of mice and required volume.
3.5 Data production from thermal images
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Thermal images shot by infrared camera were imported in the computer and
data production was done by FLIR Tools (version 5.6.16078.1002). Multiple
images were taken in each of the allocated time points but during data
production, only the best five images for each time point were taken into
account. All the images were consistent in terms of their picture properties-
dimensions of 561 x 421, horizontal and vertical resolutions of 72 dpi and bit
depth of 24. Interscapular ROI was marked within rectangular box and lower
body ROI was marked within circular/ oval boundary. Only the highest
temperature within these restricted areas was taken into consideration.
Surface temperature of skin overlying BAT within interscapular region denotes
the β3AR agonist induced BAT thermogenesis (Crane et al., 2014).
3.6 Statistical methods
All the statistical analyses were carried out using licensed GraphPad Prism
software (version 6.01). Data were presented as mean ± SEM value. P-value
of less than or equal to 0.05 (p-value ≤ 0.05) was regarded statistically
significant. The temperature (oC) vs. time point (min.) graphs were drawn for
BAT, LB and ΔT (BAT-LB) temperatures and the comparisons were made
using two way ANOVA test and Sidak’s multiple comparison test. Same kind
of comparison tests were performed for the basal temperature analysis. In
addition, magnitude of CL effect in inducing BAT thermogenesis was studied
with the help of area under the curve (AUC).
4 RESULTS
4.1 Body temperature in awake mice
BAT and LB temperatures were imaged with the help of infrared camera in
mice allowed to move freely in an individual open-top cage in a normal room
temperature without the influence of the drug or handling. Statistical test
showed marked difference between BAT and LB temperature in the
genotypes (Figure 8). BAT temperature was significantly higher than LB
temperature in both genotypes (p-value < 0.0001 body region by two-way
ANOVA). Importantly, statistically significant difference was not found in body
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temperatures between WT and MC1Re/e mice (p-value = 0.07 genotype by
two-way ANOVA, interaction of genotype and body region = not significant).
This study shows the dominance of BAT temperature over LB temperature
which is regardless of MC1R deficiency.
Figure 8: Comparison of basal temperature of BAT and LB in WT and
MC1Re/e mice. Statistically significant difference exists between BAT and LB
basal temperatures in WT and MC1Re/e mice (p-value < 0.0001). In both
genotypes, temperature of BAT is markedly higher than that of LB area. More
importantly, statistically significant difference was not found between the
genotypes’ BAT and LB temperatures (p-value = 0.07). Data are presented as
mean ± SEM. ****, p-value < 0.0001. WT- Wild type; MC1Re/e- MC1R deficient;
BAT- Brown adipose tissue; LB- Lower body.
4.2 Lack of significant differences in BAT temperature of WT and MC1Re/e
mice
CL caused an increase in BAT temperature of both, WT and MC1Re/e mice
(Figure 9A). In fact, even treatment with saline induced BAT temperature
increment in both of the genotypes except during the first time point (i.e.
00:20). However, such rise of BAT temperature caused by saline was
significantly less when compared to CL. Statistical evaluation showed
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increment of BAT temperature prominently in CL treatment group than saline
group (p-value < 0.0001). One of the important things to notice is that, within
CL group BAT temperature increment was not markedly different between WT
and MC1Re/e mice (p-value > 0.05). Along with BAT temperatures, LB
temperatures were also studied within the same set of mice. LB, deprived of
brown or beige/brite adipocytes was also our ROI as LB suitably represents
the temperature of body that lacks BAT. After the analysis, the nature of
temperature vs time points graph of LB temperatures (Figure 9B) was found to
be similar to that of BAT temperatures. However, temperatures peaked during
LB temperature measurement were considerably lower as compared to BAT
temperatures. Significant numerical differences but proportional relation
between BAT and LB temperatures was observed.
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Figure 9: Temperature (oC) vs time point (min.) graph for (A) BAT and (B) LB
temperature. Figure 9A shows statistically significant differences between the
treatment groups (p-value < 0.0001) as evaluated by multiple comparison test
which means significant temperature increment was seen in CL-injected group
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than saline-injected group. However, Sidak’s multiple comparison test within
CL injected group showed lack of statistically significant differences between
the genotypes that suggests the lack of role of MC1R in modifying BAT
temperature. Similar kind of graph was obtained for LB temperatures (Figure
9B). The main difference between these two graphs- 9A and 9B was the peak
temperature reached in individual time points. Data are presented as mean ±
SEM. ****, p-value < 0.0001. WT- Wild type; MC1Re/e- MC1R deficient; BAT-
Brown adipose tissue; LB- Lower body.
Area under the curve (AUC) against time was drawn for BAT temperatures
and analyzed by two-way ANOVA (Figure 10). AUC of BAT temperature over
time was found to be significantly higher after CL injection than saline injection
in both WT and MC1Re/e mice (p-value < 0.0001). CL-induced BAT
temperature was insignificantly lower in MC1Re/e mice than WT mice (p-value
= 0.1566 genotype).
Figure 10: AUC of BAT temperature over time in the genotypes. BAT
temperature is significantly higher following CL injection than saline injection
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in both genotypes (p-value < 0.0001). Non-significant difference was observed
in CL effect between the genotypes (p-value = 0.1566). Data are presented as
mean ± SEM. ****, p-value < 0.0001. WT- Wild type; MC1Re/e- MC1Rdeficient
4.3 Comparison of temperature difference in BAT-LB (BAT minus LB or Δt)
between wild-type and MC1Re/e mice
When proportional relation between BAT and LB temperatures from above
analysis (4.1) was realised, temperature difference between BAT and LB (Δt)
vs time point was calculated (Figure 11). Statistically significant interaction
between genotype and time (p-value < 0.05) was found in Δt of WT and
MC1Re/e mice after CL injection. The result was different for saline-treated
groups as no statistically significant difference (p-value > 0.05) was found
between the genotypes. CL-induced Δt peaked earlier in WT mice but in
MC1Re/e mice, Δt raised slowly and remained higher than WT mice that might
suggest a difference in heat transmission in β3-agonist-induced
thermogenesis possible via MC1R-mediated vasodilative action.
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Figure 11: Temperature (oC) vs time point (min.) graph for Δt in WT and
MC1Re/e mice following treatments. Significant interaction was observed
between genotype and time in CL-induced Δt of WT and MC1Re/e mice (p-
value < 0.05 for interaction in two-way ANOVA). In contrast when saline-
treated groups were compared, significant difference was not found between
WT and MC1Re/e mice. Data are presented as mean ± SEM. WT- Wild type;
MC1Re/e- MC1R deficient; BAT- Brown adipose tissue; LB- Lower body; Δt-
BAT minus LB.
AUC data showed distinctly increased Δt for CL-treated group than saline-
treated groups in WT and MC1Re/e mice (Figure 12). Statistically significant
difference was observed between saline-induced and CL-induced Δt in both
genotypes (p-value < 0.0001). Nonsignificant difference was observed when
CL-induced Δt was compared between genotypes (p-value = 0.5604).
Figure 12: AUC of BAT-LB temperature (Δt) over time in the genotypes.
Marked difference was seen between saline-treated and CL-treated group in
both genotypes (p-value < 0.0001). CL-induced Δt was nonsignificantly
different between the genotypes (p-value = 0.5604). Data are presented as




CL-316243, a highly selective β3AR agonist causes BAT mitochondrial
proliferation and thermogenesis which is linked to total energy expenditure
and leanness. In addition, CL has shown the effect in WAT hyperplasia by
impeding its growth during initial period of diet-induced obesity and also
causing WAT browning by inducing hypertrophy to small brown preadipocytes
in WAT that express β3-adrenoceptors (Himms-Hagen et al., 1994; Ghorbani
et al., 1997). In the present experiment, CL (1.00 mg/kg i.p.) was used to
acutely stimulate BAT mediated thermogenesis in mice. Injection of drug and
stress of handling of mice during the experiment increased BAT temperature
which masked the effect of drug. To solve this problem, medetomidine was
used (Cruz et al., 1998). The dose of medetomidine was kept lower (0.33
mg/kg) because the purpose was to bring mild sedation rather than
anesthesia. The light sedation prevented the mice to move frequently. Mice
were kept on the tissue paper individually over the top-grid of the cage and
thermal images were photographed by fixed top-positioned infrared camera.
Due to the mice inactive movement brought about by medetomidine, infrared
photography was performed with convenience and consistence. One of the
serious side effects of medetomidine in rodents includes hypothermia that
decreases the body temperature and can be life-threatening (Cruz et al.,
1998). To solve this issue, mice were kept on normal heating mat by which
they were able to maintain their body temperature. Heating mat was used until
the experiment lasted to consistently provide the warm surrounding to the
mice and bring uniformity in the experimental procedure. The use of heating
mat might influence the result as it increases the skin temperature of mice.
However from ethical point of view, heating mat provides survival surrounding
for sedated mice prone to intense hypothermia. In the end of experiment, mice
were injected with atipamezole (2.00 mg/kg i.p.) that reverses the effects of
medetomidine (Cruz et al., 1998). Atipamezole is an α2 agonist drug that
treats α2-mediated effects like sedation, hypothermia and acute
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cardiovascular and respiratory dysfunction (Sinclair et al., 2003). Six time
points were chosen for infrared imaging including one time point (i.e. 00:00)
before the administration of drug or saline- regarded as baseline and the other
five time points after the drug/ saline administration. Those images were taken
in every 20 minutes till 80th minute before the last imaging which was taken in
120th minute (00:20, 00:40, 01:00, 01:20 and 02:00). Decision for selecting
particular time points, doses of drug and substances and route of
administration were achieved from the data of pilot experiments performed
prior to the main experiment. To reduce treatment biasness and enhance
reproducibility, experimental mice were treated with either saline or drug in
separate days in a randomized and cross over manner.
Thermogenesis mediated by UCP1 (i.e. BAT thermogenesis) in vivo can be
specifically measured by infrared thermography (Crane et al., 2014). In the
experiment following i.p. injection with CL to UCP1-/- mice and WT (UCP1+/+)
mice, significant increase in interscapular and whole body dorsal surface
temperature was observed in UCP1+/+ mice than UCP1-/- mice. There was
also increased oxygen uptake in UCP1+/+ mice. The result suggested that
infrared thermography can accurately sense and measure UCP1-mediated
thermogenic changes in β3 stimulated mice. The experiment was also
performed in UCP1+/+ mice which were bred and housed in two different
temperatures (thermoneutral temperature of 30oC and comparatively cooler
temperature of 23oC). On β3 stimulation by CL injection, mice maintained at
23oC showed notable increase in oxygen consumption and interscapular and
whole body dorsal surface temperature than mice maintained at thermoneutral
temperature. These results have not only helped to establish a positive
correlation between whole body energy metabolism and BAT thermogenesis
but also provided evidence that changes in UCP1-mediated BAT temperature
can be evaluated by infrared thermography. The infrared thermography (IRT)
technique has been used in human subjects also to measure the surface
temperature overlying BAT-containing supraclavicular (SCV) fossa and the
lateral upper chest (Jang et al., 2014). The average left SCV temperature and
temperature difference between left or right SCV and chest (Δtemp) were
higher in BAT +ve subjects (subjects with significant amount of functional BAT)
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than BAT –ve subjects before and during cold exposure (19 oC). The
experiment showed IRT as a promising novel method to study BAT activity.
Many other experiments have also used IRT for detecting and quantifying
BAT-mediated adaptive thermogenesis in mice and human that highlights the
convenience and accuracy of this infrared-based imaging technique (Lee et al.,
2011; Symonds et al., 2012; David et al., 2013; Maurer et al., 2015; El Hadi et
al., 2016; Robinson et al., 2016; Salem et al., 2016; Ang et al., 2017; Scotney
et al., 2017).
5.2 Role of MC1R in BAT thermogenesis
MC1Re/e mice have defective MC1R function. MC1R, mainly expressed in
melanocytes of hair and skin is responsible for pigmentation (Ellacott et al.,
2006). MC1R has higher affinity towards α-MSH and ACTH. α-MSH, an
endogenous agonist gives darker pigmentation while agouti, an endogenous
antagonist gives lighter pigmentation. Effect of ligand interaction with MC1R
can be realized in agouti mice. Agouti mice are yellow in color due to the
antagonistic effect of agouti peptide in melanocyte MC1R. The agouti peptide
also acts on centrally expressed MC4R that fluctuates energy homeostasis
and produces obese phenotype. In the present experiment, MC1Re/emice are
used as genetic model for dysfunctional MC1R which have abnormal
eumelanin:pheomelanin ratio that results in lighter pigmentation (or yellow
color fur). Recent finding by Rinne et al. (2015) has shown the linkage of
disruptive MC1R signaling with increased arterial rigidity and the consequence
in endothelium-related vasodilation. Conclusively, the group suggested a
functional role of MC1R in the management of arterial tone. However, the
purpose of the present experiment for using MC1Re/e mice was concerned
only with their obese phenotype. BAT thermogenesis is regulated by the CNS
with the main involvement of CMS that consists of MC3R and MC4R (Girardet
and Butler, 2014; Contreras et al, 2015). CMS helps in energy homeostasis by
influencing whole body energy metabolism and adaptive thermogenesis via
hormonal and central pathway. Because of the CMS crucial role in body
weight maintenance, it is not surprising that rodents lacking CMS receptors
produce obese phenotype. Treating APOE*3-Leiden.CETP transgenic mice
with SHU9119, Kooijman et al. (2014) showed inhibition of central MC3/4R
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pathway disrupts BAT function, along with decreasing EE and increasing
adiposity. One of our previous experiment conducted by different researchers
showed similar kind of reduced EE and higher adipose tissue mass in
MC1Re/e mice. The present experiment tried to address the reason behind
such observational changes in MC1Re/e mutant mice and if BAT activity is
involved in the process. In the experiment, BAT activity was stimulated by
exogenously administered β3-adrenoceptor agonist (CL-316243) as BAT
contains rich amount of specific β3 nerves. The endpoint response of BAT
activation is observed by the increment in BAT temperature (thermogenesis)
mediated by UCP1, a specific mitochondrial protein expressed in brown
adipocytes. Increased BAT temperature was assessed by infrared
thermography (IRT) technique by measuring superficial temperature of
interscapular ROI underlying BAT. To compare the BAT temperature with
other areas of body, IRT was also used to measure lower body area
temperature in the same mice simultaneously.
Results obtained from the current experiment can be discussed in two main
points- one when thermogenesis was measured in basal state and another
when thermogenesis was stimulated by using CL. On the second day of each
experimental week, both genotypes from the respective study groups were
measured for its BAT and LB temperature in an unstimulated normal room
temperature (21oC). Mice were first transferred to individual new cage, left
there for two hours without any food or water then top grid of cage was
removed and left for another half an hour. Thermography was done with top-
mounted infrared camera. The study on basal temperature revealed that BAT
temperature is always higher than temperature of body that do not overly BAT.
When CL-induced rising BAT temperatures were compared between the
genotypes, statistically significant difference was not observed that simply
implicated the lack of the MC1R role in maintaining basal temperature.
However, one can oppose the notion as there is a natural tendency for a
decreasing body temperature. Conclusively, MC1R does not interfere in basal
temperature and the temperature of region that overly BAT is consistently
higher than that region which lacks BAT, as detected by IRT. Next, the
present experiment analyzed β3-agonist-induced BAT thermogenesis in WT
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and MC1Re/e mice. When data obtained from thermographed images were
statistically evaluated, it did not yield significant difference between the
genotypes. Two-way ANOVA tests of measured BAT temperature in different
time points showed statistically significant difference between saline-treated
and CL-treated group but not between genotypes. Since it is well established
fact that CL stimulates BAT thermogenesis (Himms-Hagen et al., 1994), the
positive rise of BAT temperature observed in CL-treated groups was not a
novel finding but the lack of significant difference between CL-treated
genotypes suggests for the first time that there is no active role of MC1R in
regulating BAT thermogenesis. Our experimental setting easily demonstrated
the thermogenesis effect of CL in mice. Furthermore when temperature
difference between BAT-LB (Δt) was compared among genotypes, the
differences were significantly different between the genotypes over time with
slower increase and larger temperature difference in MC1Re/e mice. In-detail
comparison of Δt between the groups showed prominent difference between
saline-treated and CL-treated group in WT mice in the first 20 minutes time.
However, in MC1Re/e mice such significant difference was observed in later
time points (i.e. in all time points except the first 20 minutes). The result
showed that difference between CL-induced Δt and saline-induced Δt was
significantly larger in MC1Re/e mice than WT mice which is observed in later
time points. The analysis entails MC1R is somehow responsible for
inconsistent rate of heat distribution produced by β3 activation. In a living
body, heat is distributed via circulatory mechanism. Heat generated in BAT by
β3 stimulation is transmitted to peripheral organs through blood.
Disproportionate temperature variation in BAT-LB in MC1Re/e mice might be
associated with impaired vasodilatation. Although MC1Re/e mice have
defective MC1R, they have functional MC3/4R- the main components of CMS
which is sole responsible for hypothalamic control of brown fat thermogenesis.
This is the reason why MC1Re/e mice were still able to produce thermogenic
response to β3 drug alike their WT counterparts. This theory however fails to
justify the reason behind decreased energy expenditure and increased
adiposity observed in MC1Re/e mice. MC1R has also been detected in
periaqueductal gray matter as suggested by anatomical studies (Xia et al.,
1995) aided by its physiological role in nociception and anti-inflammation
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(Caruso et al., 2014) but its direct role in energy homeostasis is not properly
explained. The present experiment was able to demonstrate the lack of role of
MC1R in brown fat thermogenesis but to describe the reason behind it in
molecular level, further researches are required. These MC1R deficiency-
related hypometabolism and weight gain could be linked with CMS-
independent pathway that modulates energy homeostasis. Indeed, this
assumption was further supported by observation when MC1Re/emice showed
similar effect as WT mice during the basal temperature measurement.
Feeding behavior and energy expenditure are two main factors that lead to
obesity, a metabolic disorder characterized by increased fat with
cardiovascular and hyperglycemic complications. Currently, it affects large
population worldwide i.e. 13% of world’s adult population (WHO Factsheets,
2014) and is responsible for comorbid conditions like hypertension, type 2
diabetes mellitus, dyslipidemia, other cardiovascular diseases, stroke,
gallbladder disorder, gout and osteoarthritis (Khaodhiar et al., 1999). Clinical
manifestation observed in obese is due to excessive fat mass accumulation
and this abnormal weight gain is centrally controlled by CNS which involves
key neuronal system called melanocortin system. Through various neural
pathways, melanocortin system impacts diverse kind of physiological
processes from pigmentation to energy homeostasis and from
steroidogenesis to exocrinal secretion. Most important of all, central
melanocortin system role in influencing energy intake, satiety and energy
expenditure via centrally expressed MC3/4R and endogenous melanocortin
peptides (α-MSH and AgRP) directly relates to body weight regulation (Hill
and Faulkner, 2017). Hypothalamic control of brown fat thermogenesis works
downstream to CMS leading to the dissipation of stored energy as heat from
the body (Cannon and Nedergaard, 2004). Circulating plasma level of
anorexigenic α-MSH was lower and that of orexigenic AgRP was higher in
obese children highlighting the role of these melanocortin peptides in the
regulation of appetite (Vehapoglu et al., 2016). α-MSH is an important
endogenous ligand in melanocortin system as its binding to melanocortin
receptors show significant functions like pigmentation (MC1R) and appetite
suppression (MC3/4R). Conversely, these melanocortin receptors work via
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same ligands to show diverse kind of physiological function. Although the data
obtained from the current experiment were not sufficient to explain the weight
gain in MC1Re/e mice on a genetic basis, one can postulate that the adiposity
seen in these mutant mice might be due to presumed alternative feeding
behavior accompanied by decreased energy expenditure but irrespective of
BAT thermogenesis. In the experiment, the basal temperature was measured
on the basis of thermogenic response and it did not show any significant
differences between MC1R-deficient and WT mice strengthening the fact that
feeding action is causing over-weight. Lack of MC1R in mice might affect
hormonal and neuronal pathways leading to the change in feeding behavior
(mealing frequency and meal size) causing alteration in body weight.
Additionally, prior experiment has shown deficiency in MC1R causes
reduction in energy expenditure. Combining the observed evidences, it can be
encapsulated that MC1R does not influence BAT thermogenesis and basal
temperature but it can affect the appetite-hunger balance causing increase in
adipose tissue mass, accompanied by decreased energy expenditure. Apart
from MC1R function in skin/ hair pigmentation, pain response modification and
anti-inflammatory reaction, more research can establish MC1R as a novel
target for treating obesity as scientific work have demonstrated its deficiency
causes weight gain.
6 CONCLUSION
It is not a recent discovery that profound the importance of melanocortin
system in the central control of energy homeostasis. With the help of
antagonistically binding ligands and centrally expressed melanocortin
receptors, this system is epitomized as overseer of energy balance regulation.
Developments in neuroscience and molecular biology had helped scientific
community to grab a better understanding in melanocortinergic neuronal and
signaling pathways and their direct involvement in hunger, satiety, energy
expenditure, glycemic equilibrium and sympathetic rush. On the other hand,
recent confirmation of presence of BAT in adult humans (previously thought to
be present only in neonates) had intensified scientific work on brown fat and
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attempts are being carried out to activate or enlarge this tissue by external
means to develop new pharmacotherapy for obesity and related disorders.
The common role of melanocortin system and brown fat in energy expenditure
and body weight regulation has led researchers to reckon the relationship
between these two energy-regulating factors. Not surprisingly, it was found
that central melanocortin system regulates energy expenditure via BAT and
modulation of either of these can be proved as beneficial for obesity and
associated complications. But, the side-effects they can cause by selectively
targeting these receptors and ligands are in investigation phase. In such
regard, the present experiment has studied if any relationship exists between
particular member of melanocortin receptor family (i.e. MC1R) and the main
thermogenic organ (BAT) in the induction of non-shivering thermogenesis.
Despite our finding showing lack of any association between MC1R and BAT,
the role of MC1R in modifying whole body energy expenditure and weight
variation as revealed by previous experiment can still prove as effective in
conducting further works to study MC1R and its potential to unearth new
attractive target for anti-obesity medication.
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8 ABBREVIATIONS LIST
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AGRP – Agouti-Related Protein
ARC – Arcuate nucleus
β3AR – Beta-3 Adrenergic Receptor
BAT – Brown Adipose Tissue
CIT – Cold-Induced Thermogenesis
CMS – Central Melanocortin System
CNS – Central Nervous System
DIT – Diet-Induced Thermogenesis
EE – Energy Expenditure
iBAT – Interscapular BAT
IRT – Infrared Thermography
MC1R – Melanocortin 1 Receptor
POMC – Proopiomelanocortin
UCP1 – Uncoupling Protein 1
WAT – White Adipose Tissue
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